Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hepatotoxicity of alogliptin.
Barbehenn E, Almashat S, Carome M, Wolfe S. Barbehenn E, et al. Clin Pharmacokinet. 2014 Nov;53(11):1055-6. doi: 10.1007/s40262-014-0199-1. Clin Pharmacokinet. 2014. PMID: 25336392 No abstract available.
Information on thiazolidinediones.
Wolfe SM, Lurie P, Sasich LD, Barbehenn E. Wolfe SM, et al. Among authors: barbehenn e. Lancet. 2000 Jul 15;356(9225):254-5. doi: 10.1016/S0140-6736(05)74507-4. Lancet. 2000. PMID: 10963229 No abstract available.
Alosetron for irritable bowel syndrome.
Barbehenn E, Lurie P, Wolfe SM. Barbehenn E, et al. Lancet. 2000 Dec 9;356(9246):2009-10. doi: 10.1016/S0140-6736(05)72978-0. Lancet. 2000. PMID: 11130544 No abstract available.
Safety of sildenafil citrate.
Wolfe SM, Sasich L, Barbehenn E. Wolfe SM, et al. Among authors: barbehenn e. Lancet. 1998 Oct 24;352(9137):1393. doi: 10.1016/S0140-6736(05)60794-5. Lancet. 1998. PMID: 9802308 No abstract available.
Osteosarcoma risk in rats using PTH 1-34.
Barbehenn EK, Lurie P, Wolfe SM. Barbehenn EK, et al. Trends Endocrinol Metab. 2001 Nov;12(9):383. doi: 10.1016/s1043-2760(01)00489-1. Trends Endocrinol Metab. 2001. PMID: 11595538 No abstract available.
25 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page